QRX-401

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameQRX-401
Drug Alias NameSR-103912QRX-401
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein A-I inhibitors
TargetsApolipoprotein A-I
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofiGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A